Company: WHWK
Filing Date: 2025-08-07
Form Type: 10-Q
Source: 0000950170-25-105081
Chunk: 6

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-08-07
Form: 10-Q
Item: Item 6
Chunk 6
---
18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

     32.2**
      
     Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

     101.INS
      
     Inline XBRL Instance Document

     101.SCH
      
     Inline XBRL Taxonomy Extension Schema Document

     104
      
     Cover Page Interactive Data File (formatted as inline XBRL with applicable taxonomy extension information contained in Exhibits 101.)

* Filed herewith.

** The certifications furnished in Exhibits 32.1 and 32.2 hereto are deemed to be furnished with this Quarterly Report on Form 10-Q and will not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, except to the extent that the Registrant specifically incorporates it by reference.